432 related articles for article (PubMed ID: 24120822)
21. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 Clinical Trial of Simultaneous Boost Intensity Modulated Radiation Therapy With 3 Dose Gradients in Patients With Stage I-II Nasal Type Natural Killer/T-Cell Lymphoma: Long-Term Outcomes of Survival and Quality of Life.
Niu S; Li Y; Shao H; Hu J; Wang J; Wang H; Zhang Y
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):770-780. PubMed ID: 37939733
[TBL] [Abstract][Full Text] [Related]
24. Can dose reduction to one parotid gland prevent xerostomia?--A feasibility study for locally advanced head and neck cancer patients treated with intensity-modulated radiotherapy.
Anand AK; Jain J; Negi PS; Chaudhoory AR; Sinha SN; Choudhury PS; Kumar R; Munjal RK
Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):497-504. PubMed ID: 16909975
[TBL] [Abstract][Full Text] [Related]
25. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
[TBL] [Abstract][Full Text] [Related]
26. Intensity-modulated radiotherapy vs. parotid-sparing 3D conformal radiotherapy. Effect on outcome and toxicity in locally advanced head and neck cancer.
Lambrecht M; Nevens D; Nuyts S
Strahlenther Onkol; 2013 Mar; 189(3):223-9. PubMed ID: 23319256
[TBL] [Abstract][Full Text] [Related]
27. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?
Chang DT; Amdur RJ; Pacholke H; Mendenhall NP; Morris CG; Byer GA; Olivier KR
Am J Clin Oncol; 2009 Apr; 32(2):145-9. PubMed ID: 19307951
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy alone with curative intent in patients with stage I extranodal nasal-type NK/T-cell lymphoma.
Li YX; Wang H; Jin J; Wang WH; Liu QF; Song YW; Wang ZY; Qi SN; Wang SL; Liu YP; Liu XF; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1809-15. PubMed ID: 21470789
[TBL] [Abstract][Full Text] [Related]
29. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
30. Level II lymph nodes and radiation-induced xerostomia.
Astreinidou E; Dehnad H; Terhaard CH; Raaijmakers CP
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):124-31. PubMed ID: 14697429
[TBL] [Abstract][Full Text] [Related]
31. Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents.
Wang ZY; Li YX; Wang WH; Jin J; Wang H; Song YW; Liu QF; Wang SL; Liu YP; Qi SN; Fang H; Liu XF; Yu ZH
Blood; 2009 Nov; 114(23):4771-6. PubMed ID: 19812381
[TBL] [Abstract][Full Text] [Related]
32. Intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for stage I-II natural killer/T-cell lymphoma nasal type: dosimetric and clinical results.
Shen Q; Ma X; Hu W; Chen L; Huang J; Guo Y
Radiat Oncol; 2013 Jun; 8():152. PubMed ID: 23800149
[TBL] [Abstract][Full Text] [Related]
33. Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
Poorvu PD; Sadow CA; Townamchai K; Damato AL; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1262-8. PubMed ID: 23182395
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
Han L; Lin SJ; Pan JJ; Chen CB; Zhang Y; Zhang XC; Liao XY; Chen QS
Chin J Cancer; 2010 Feb; 29(2):145-50. PubMed ID: 20109341
[TBL] [Abstract][Full Text] [Related]
35. Parotid gland radiation dose-xerostomia relationships based on actual delivered dose for nasopharyngeal carcinoma.
Lou J; Huang P; Ma C; Zheng Y; Chen J; Liang Y; Li H; Yin Y; Liu D; Yu G; Li D
J Appl Clin Med Phys; 2018 May; 19(3):251-260. PubMed ID: 29664218
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
37. Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: an update of the Memorial Sloan-Kettering Cancer Center experience.
Setton J; Caria N; Romanyshyn J; Koutcher L; Wolden SL; Zelefsky MJ; Rowan N; Sherman EJ; Fury MG; Pfister DG; Wong RJ; Shah JP; Kraus DH; Shi W; Zhang Z; Schupak KD; Gelblum DY; Rao SD; Lee NY
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):291-8. PubMed ID: 21167652
[TBL] [Abstract][Full Text] [Related]
38. Intensity Modulated Radiation Therapy for Early-Stage Primary Gastric Diffuse Large B-Cell Lymphoma: Dosimetric Analysis, Clinical Outcome, and Quality of Life.
Liu X; Fang H; Tian Y; Wang WH; Song YW; Wang SL; Liu YP; He XH; Dong M; Ren H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2016 Jun; 95(2):712-20. PubMed ID: 27034178
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience.
Lee N; Xia P; Quivey JM; Sultanem K; Poon I; Akazawa C; Akazawa P; Weinberg V; Fu KK
Int J Radiat Oncol Biol Phys; 2002 May; 53(1):12-22. PubMed ID: 12007936
[TBL] [Abstract][Full Text] [Related]
40. Near Real-Time Assessment of Anatomic and Dosimetric Variations for Head and Neck Radiation Therapy via Graphics Processing Unit-based Dose Deformation Framework.
Qi XS; Santhanam A; Neylon J; Min Y; Armstrong T; Sheng K; Staton RJ; Pukala J; Pham A; Low DA; Lee SP; Steinberg M; Manon R; Chen AM; Kupelian P
Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):415-22. PubMed ID: 25847607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
